| Stat3 as an oncogene. | None |
| Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. | None |
| Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. | None |
| IL-6 induces expression of the Fli-1 proto-oncogene via STAT3. | None |
| STAT5b-RARalpha and other APL fusion proteins may contribute to leukemogenesis by interaction with the STAT3 oncogene pathway. | None |
| Considering the functional association of the two proteins, the overexpression of ERp57 observed in a variety of transformed cells might be relevant to the oncogenic properties of STAT3. | None |
| Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. | None |
| Knockdown of Stat3 in C17.2 neural stem cells facilitates the generation of neurons: a possibility of transplantation with a low level of oncogene. | None |
| STAT3: a multifaceted oncogene. | None |
| The STAT3 oncogene as a predictive marker of drug resistance. | None |
| Expression of STAT3 and Bcl-6 oncoprotein in sodium arsenite-treated SV-40 immortalized human uroepithelial cells. | None |
| Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate Stat3 at a posttranslational level in NIH3T3 cells. | None |
| The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition. | None |
| Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. | None |
| Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). | None |
| The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac. | None |
| Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors. | None |
| The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor. | None |
| Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. | None |
| Studies indicate that STAT3 plays dual tumor suppressive and oncogenic roles in glial malignancy depending on the mutational profile of the tumor. | None |